{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:22:29Z","timestamp":1750004549562},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T00:00:00Z","timestamp":1432252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0127062","type":"journal-article","created":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T17:53:10Z","timestamp":1432317190000},"page":"e0127062","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Serious Adverse Events Are Uncommon with Combination Neonatal Antiretroviral Prophylaxis: A Retrospective Case Review"],"prefix":"10.1371","volume":"10","author":[{"given":"Christiana","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeri E.","family":"Forster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron J.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay","family":"Kinzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Barr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,5,22]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/QAD.0b013e328350995c","article-title":"A national review of vertical HIV transmission","volume":"26","author":"JC Forbes","year":"2012","journal-title":"AIDS"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/01.qai.0000224571.30119.3d","article-title":"Children born to HIV-1-infected women in Sweden in 1982\u20132003: trends in epidemiology and vertical transmission","volume":"42","author":"L Naver","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref3","unstructured":"Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States 2014 [cited 6 June 2014]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/PerinatalGL.pdf\" xlink:type=\"simple\">http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/PerinatalGL.pdf<\/ext-link>."},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/apc.2010.0255","article-title":"Postnatal infant HIV prophylaxis: a survey of U.S. practice","volume":"25","author":"K McKeegan","year":"2011","journal-title":"AIDS Patient Care STDS"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/QAD.0b013e32835cffb1","article-title":"Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants","volume":"27","author":"E Chiappini","year":"2013","journal-title":"AIDS"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1468-1293.2010.00902.x","article-title":"Use of neonatal post-exposure prophylaxis for prevention of mother-to-child HIV transmission in the UK and Ireland, 2001\u20132008","volume":"12","author":"H Haile-Selassie","year":"2011","journal-title":"HIV Med"},{"issue":"19","key":"ref7","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa1302976","article-title":"Absence of detectable HIV-1 viremia after treatment cessation in an infant","volume":"369","author":"D Persaud","year":"2013","journal-title":"N Engl J Med"},{"issue":"16","key":"ref8","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.285.16.2083","article-title":"Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1","volume":"285","author":"L Mandelbrot","year":"2001","journal-title":"JAMA"},{"issue":"25","key":"ref9","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1056\/NEJMoa1108275","article-title":"Three postpartum antiretroviral regimens to prevent intrapartum HIV infection","volume":"366","author":"K Nielsen-Saines","year":"2012","journal-title":"N Engl J Med"},{"key":"ref10","unstructured":"National Institutes of Health. Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events 2004 [cited 1 October 2010]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.niaid.nih.gov\/LabsAndResources\/resources\/DAIDSClinRsrch\/Documents\/daidsaegradingtable.pdf\" xlink:type=\"simple\">http:\/\/www.niaid.nih.gov\/LabsAndResources\/resources\/DAIDSClinRsrch\/Documents\/daidsaegradingtable.pdf<\/ext-link>."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"867674","DOI":"10.1155\/2011\/867674","article-title":"Safety and tolerability of antiretrovirals during pregnancy","volume":"2011","author":"A Weinberg","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcv.2009.02.009","article-title":"Resistance to antiretrovirals in HIV-infected pregnant women","volume":"45","author":"A Weinberg","year":"2009","journal-title":"J Clin Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"621780","DOI":"10.1155\/2009\/621780","article-title":"Kinetics and determining factors of the virologic response to antiretrovirals during pregnancy","volume":"2009","author":"A Weinberg","year":"2009","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"RR-2","key":"ref14","first-page":"1","article-title":"Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccell.2004.02.010","article-title":"Neonatal jaundice: physiologic variation or pathologic process","volume":"16","author":"DJ Reiser","year":"2004","journal-title":"Critical care nursing clinics of North America"},{"issue":"Suppl 1","key":"ref16","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/00126334-200309011-00013","article-title":"Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy","volume":"34","author":"JS Montaner","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00002030-200301240-00023","article-title":"Case report: nucleoside analogue-induced lactic acidosis in the third trimester of pregnancy","volume":"17","author":"L Mandelbrot","year":"2003","journal-title":"AIDS"},{"key":"ref18","unstructured":"Singh A, Hemal A, Agarwal S, Dubey N, Buxi G. A prospective study of haematological changes after switching from stavudine to zidovudine-based antiretroviral treatment in HIV-infected children. International journal of STD &amp; AIDS. 2014: In press."},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"e806","DOI":"10.1016\/j.ijid.2013.04.006","article-title":"Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy","volume":"17","author":"T Bunupuradah","year":"2013","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1086\/425903","article-title":"Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332","volume":"190","author":"NA Wade","year":"2004","journal-title":"J Infect Dis"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1128\/AAC.45.12.3585-3590.2001","article-title":"Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates","volume":"45","author":"C Rongkavilit","year":"2001","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/QAI.0b013e31815f3c23","article-title":"Nevirapine concentrations in newborns receiving an extended prophylactic regimen","volume":"47","author":"M Mirochnick","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00126334-200312150-00006","article-title":"Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months","volume":"34","author":"AK Shetty","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/INF.0b013e3182242950","article-title":"Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life","volume":"30","author":"M Mirochnick","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"ref25","unstructured":"U.S. Food and Drug Administration. Kaletra (lopinavir\/ritonavir) Oral Solution label changes related to toxicity in preterm neonates 2011 [cited 5 June 2014]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/ForConsumers\/ByAudience\/ForPatientAdvocates\/HIVandAIDSActivities\/ucm244639.htm\" xlink:type=\"simple\">http:\/\/www.fda.gov\/ForConsumers\/ByAudience\/ForPatientAdvocates\/HIVandAIDSActivities\/ucm244639.htm<\/ext-link>."},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/INF.0b013e31818cc053","article-title":"Early initiation of lopinavir\/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy","volume":"28","author":"EG Chadwick","year":"2009","journal-title":"Pediatr Infect Dis J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0127062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T23:37:06Z","timestamp":1652053026000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0127062"}},"subtitle":[],"editor":[{"given":"Soren","family":"Gantt","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,22]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0127062","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,22]]}}}